Study participation

Evaluation & duration

The new instrument will be tested from July 2022 in two rounds (piloting, main study). For this purpose, patients with depressive symptoms will be interviewed by their general practitioners in a standardized interview (approx. 15-20 minutes) after an informative discussion. The patients are then given a few more questionnaires to complete (approx. 20 minutes). Both the doctors and the participating patients receive an expense allowance for this service.

Possible benefits of participating in the study

With your participation you support our clinical research project to hopefully better recognize suicidal tendencies in at-risk patients in Germany in the future and to be able to take preventive measures. In this study, a newly developed questionnaire will be converted into a short version and validated, and its applicability in general practice will be tested. If good diagnostic parameters are obtained and good applicability in general practice is demonstrated, you will learn about a time-efficient and valid screening instrument for the future as a contribution to suicide prevention in adults. The protective factors will provide starting points for possible interventions.

Possible risks of participating in the study

As this is a non-invasive diagnostic study, no patient risk is generally to be expected when conducting this study. Actively asking about possible suicidal thoughts/suicidal plans has not been shown to increase the risk of suicide.

If you are interested, please contact:

Carolin Haas, M.Sc. psychologist

Mail: c.haas@med.uni-muenchen.de

Tel: 089 / 4400 54978

Mobile: 0179 / 4602996

Official project website: https://pokal-kolleg.de/projekte/suizidalitaet/